These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 33950348)

  • 61. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
    Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
    Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of a prolonged lockdown and utilization of diabetes telemedicine on cardiometabolic health in people with diabetes during the COVID-19 outbreak in Saudi Arabia.
    Al-Sofiani ME; AlMesned RK; Bafadel MS; Alguwaihes AM; Alfadda AA
    Prim Care Diabetes; 2022 Oct; 16(5):644-649. PubMed ID: 35773134
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.
    Takahara M; Watanabe H; Shiraiwa T; Maeno Y; Yamamoto K; Shiraiwa Y; Yoshida Y; Nishioka N; Katakami N; Shimomura I
    J Diabetes Investig; 2022 Feb; 13(2):375-385. PubMed ID: 33768726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HbA1c and BMI after lockdown for COVID-19 in children and adolescents with type 1 diabetes mellitus.
    Cognigni M; D'Agostin M; Schiulaz I; Giangreco M; Carletti C; Faleschini E; Barbi E; Tornese G
    Acta Paediatr; 2021 Jul; 110(7):2206-2207. PubMed ID: 33709538
    [No Abstract]   [Full Text] [Related]  

  • 65. Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Wafa IA; Pratama NR; Sofia NF; Anastasia ES; Konstantin T; Wijaya MA; Wiyono MR; Djuari L; Novida H
    Diabetes Metab J; 2022 Mar; 46(2):260-272. PubMed ID: 35255551
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic.
    Salinero-Fort MA; San Andrés-Rebollo FJ; Cárdenas-Valladolid J; Mostaza J; Lahoz C; Rodriguez-Artalejo F; Gómez-Campelo P; Vich-Pérez P; Jiménez-García R; de-Miguel-Yanes JM; Maroto-Rodriguez J; Taulero-Escalera B; Campo VI;
    BMC Geriatr; 2024 Jun; 24(1):533. PubMed ID: 38902647
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
    Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
    Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence.
    Bandarian F; Qorbani M; Aalaa M; Peimani M; Larijani B; Nasli-Esfahani E
    Prim Care Diabetes; 2023 Jun; 17(3):238-241. PubMed ID: 36935271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.
    Palanca A; Quinones-Torrelo C; Girbés J; Real JT; Ampudia-Blasco FJ
    Eur J Clin Invest; 2022 Jun; 52(6):e13771. PubMed ID: 35313009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retrospective Study on the Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes in Northern Taiwan.
    Huang H; Su HL; Huang CH; Lin YH
    Diabetes Metab Syndr Obes; 2023; 16():2539-2547. PubMed ID: 37645235
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metabolic control during the SARS-CoV-2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV initiative.
    Hammersen J; Reschke F; Tittel SR; Pappa A; Dost A; Köstner K; Rosenbauer J; Kapellen TM; Rohrer TR; Holl RW
    Pediatr Diabetes; 2022 May; 23(3):351-361. PubMed ID: 35084805
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting.
    Di Dalmazi G; Coluzzi S; Baldassarre MPA; Sorbo SE; Dell'Aquila S; Febo F; Ginestra F; Graziano G; Rossi MC; Consoli A; Formoso G
    Clin Ther; 2020 Sep; 42(9):1738-1749.e1. PubMed ID: 32753164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia.
    Sendekie AK; Teshale AB; Tefera YG
    PLoS One; 2022; 17(5):e0268639. PubMed ID: 35617250
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glycemic control rate of T2DM outpatients in China: a multi-center survey.
    Chen R; Ji L; Chen L; Chen L; Cai D; Feng B; Kuang H; Li H; Li Y; Liu J; Shan Z; Sun Z; Tian H; Xu Z; Xu Y; Yang Y; Yang L; Yu X; Zhu D; Zou D
    Med Sci Monit; 2015 May; 21():1440-6. PubMed ID: 25986070
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Impact of COVID-19 Lockdown on the Incidence of Type 1 DM and the Glycemic Control of Diabetic Children: Findings from a Teaching Hospital, Saudi Arabia.
    Al-Qahtani MH; Bukhamseen FM; Al-Qassab AT; Yousef AA; Awary BH; Albuali WH; Alkhalifa ZM; Yousef HA
    Rev Diabet Stud; 2022 Sep; 18(3):152-156. PubMed ID: 36309774
    [No Abstract]   [Full Text] [Related]  

  • 77. Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus.
    Mochizuki S; Miura J; Takagi S; Takita M; Takaike H; Babazono T
    Intern Med; 2024 May; 63(9):1197-1205. PubMed ID: 38369358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscany.
    Bellini B; Nreu B; Francesconi P; Mannucci E
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2588-2593. PubMed ID: 36064691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: A systematic review and meta-analysis.
    O'Mahoney LL; Highton PJ; Kudlek L; Morgan J; Lynch R; Schofield E; Sreejith N; Kapur A; Otunla A; Kerneis S; James O; Rees K; Curtis F; Khunti K; Hartmann-Boyce J
    Diabetes Obes Metab; 2022 Sep; 24(9):1850-1860. PubMed ID: 35603919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of work status changes and perceived stress onglycaemiccontrol in individuals with type 1 diabetes during COVID-19 lockdown in Italy.
    Barchetta I; Cimini FA; Bertoccini L; Ceccarelli V; Spaccarotella M; Baroni MG; Cavallo MG
    Diabetes Res Clin Pract; 2020 Dec; 170():108513. PubMed ID: 33075424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.